Literature DB >> 16473351

The effects of metronidazole and furazolidone during Giardia differentiation into cysts.

Moema A Hausen1, Julio Cesar M Freitas, Luiz Henrique Monteiro-Leal.   

Abstract

The protozoon Giardia lamblia infects millions of people worldwide, most of them in underdeveloped countries, where it is frequently a hyperendemic disease. The search for an effective anti-Giardia treatment has been intense, but recurrent infections, virulence factors, and drug resistance imposed obstacles in the achievement of an efficient medication. Most papers about drug effects in Giardia are related to the trophozoite form, although viable cysts, the infective forms, are continuously eliminated in the stools during the treatment. Supported by this knowledge, we analyzed the inhibitory effects of metronidazole (MZ) and furazolidone (FZ) on the differentiation of Giardia into cysts and its viability. The presence of cavities, lamellar bodies and thread-like structures were the most frequent morphological alterations. The results showed also that FZ was more effective by 50% than MZ in inhibiting in vitro cyst differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473351     DOI: 10.1016/j.exppara.2005.12.009

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.

Authors:  Dayane Andriotti Otta; Fernanda Fortes de Araújo; Vitor Bortolo de Rezende; Elaine Maria Souza-Fagundes; Silvana Maria Elói-Santos; Matheus Fernandes Costa-Silva; Raiany Araújo Santos; Heloísa Alves Costa; Jair Lage Siqueira-Neto; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Clathrin-dependent pathways and the cytoskeleton network are involved in ceramide endocytosis by a parasitic protozoan, Giardia lamblia.

Authors:  Yunuen Hernandez; Cynthia Castillo; Sukla Roychowdhury; Adrian Hehl; Stephen B Aley; Siddhartha Das
Journal:  Int J Parasitol       Date:  2006-10-12       Impact factor: 3.981

3.  Giardia intestinalis thymidine kinase is a high-affinity enzyme crucial for DNA synthesis and an exploitable target for drug discovery.

Authors:  Sascha Krakovka; Farahnaz Ranjbarian; Lucas A Luján; Alicia Saura; Nicolai B Larsen; Alejandro Jiménez-González; Anna Reggenti; Hugo D Luján; Staffan G Svärd; Anders Hofer
Journal:  J Biol Chem       Date:  2022-05-11       Impact factor: 5.486

4.  Giardia lamblia: a report of drug effects under cell differentiation.

Authors:  Moema A Hausen; Richard Pereira de Oliveira; Ana Paula Rocha Gadelha; Loraine Campanati; Jorge José de Carvalho; Laís de Carvalho; Helene Santos Barbosa
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

Review 5.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

Review 6.  Treatment-refractory giardiasis: challenges and solutions.

Authors:  Marco Lalle; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

7.  Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial Pathway.

Authors:  Chongshan Dai; Daowen Li; Lijing Gong; Xilong Xiao; Shusheng Tang
Journal:  Molecules       Date:  2016-08-22       Impact factor: 4.411

8.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.